BioOutsource, a global provider of biologics contract testing and biosimilar characterization for the biopharmaceutical industry, plans to open a new North American testing facility in 2015. The last year has been an exceptional growth year for the company: global demand for outsourced testing services, coupled with BioOutsource’s continued investment in R&D and the opening of a BioSimilar Center of Excellence in Glasgow in February, has created the need to establish a new testing facility.

Following the opening of a U.S. office in 2013 in Cambridge, Mass., the company plans to open a laboratory facility in the Massachusetts area in early 2015 to service North American and Latin American clients. The new laboratory facility will support and strengthen the company’s BioSimilar and BioSafety service offering.

“North America always has been an essential strategic element of our global expansion plans, exemplified by our U.S. office and active membership of MassBio. We already are a global company and the time is right to extend our global client footprint with the addition of a new facility in the U.S. The new facility will benefit our existing and new clients, improving logistics and ensuring our technical experts are close by.”